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Bulleted statements 
What is already known about this topic? 
- Gain of function mutations in NLRC4 have recently been found to be associated with 
autoinflammatory disease, presenting predominantly with recurrent febrile episodes, urticarial 
skin rash and enterocolitis. 
 
What does this study add? 
- We report a novel NLRC4 variant that is associated with autoinflammatory disease, and provide 
a detailed description of the phenotype in a 6-generation pedigree.  
- It is the first report of cutaneous histopathological findings in patients with gain of function 
mutations in NLRC4. Skin biopsies showed a dermal lymphocytic-histiocytic infiltrate, a feature 
that has not been described before in autoinflammatory skin disease. 
 
Dear Editor,  
 
Autoinflammatory disorders (AID) are a heterogeneous group of diseases, characterized by an 
unprovoked innate immune response, resulting in recurrent or ongoing systemic inflammation and 
fever1-3. Inflammasomes are protein complexes with an essential role in pyroptosis and the caspase-1-
mediated activation of the proinflammatory cytokines IL-1β, IL-17 and IL-18 (reviewed in4,5). Excessive 
activation of inflammasomes results in systemic autoinflammatory disease. Various inflammasomes 
have been identified, of which the NLRP3 inflammasome is most widely studied. Gain of function 
mutations in the NLRP3 gene are associated with cryopyrin-associated periodic syndromes (CAPS), with 
urticarial skin rash as one of the hallmarks6,7. Recently, gain of function mutations in NLRC4 
(IPAF/CARD12) were found to associate with a clinically heterogeneous AID, characterized by recurrent 
episodes of fever, periodic urticarial rash, enterocolitis, splenomegaly, and macrophage activation 
syndrome (MAS)8-10. Five different mutations in NLRC4 have been reported8-10 (reviewed in 11). 
Gastrointestinal symptoms and hemophagocytosis distinguish the NLRC4-associated phenotype from 
CAPS8 .  
In this study, we describe the phenotype and skin histology of a large pedigree with 13 affected 
family members due to a novel mutation in NLRC4 (pedigree in suppl. Fig. 1).   
Disease onset occurred in infancy in all patients. Symptoms could be triggered by changes in 
weather conditions, emotional stress, and infection. Disease episodes were characterized by skin 
lesions, conjunctivitis, arthralgias, and - in two patients - colitis. Skin lesions, the predominant feature, 
varied in severity and localization. In contrast to previous reports, we observed different skin 
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phenotypes between the pediatric and adult patients 8-10. The adult patients had painful erythematous 
nodes on the lower legs and feet, either isolated or in combination with urticarial patches on arms, legs, 
trunk and face. In two patients, soles were involved, which had not been reported before in AIDs. 
Remarkably, the pediatric cases in our cohort suffered from urticarial rash only (Fig. 1a).  
One patient had enterocolitis with histological signs of inflammatory bowel disease, a feature 
that was previously described9. Histological evaluation of colon biopsies revealed active inflammation, 
with moderate infiltration of neutrophilic granulocytes and a submucosal mononuclear infiltrate. In 
contrast to the other reports where neonatal-onset enterocolitis spontaneously resolved after the age 
of 1 year, the onset of enterocolitis in our patient was in adulthood, with a chronic course8. The low 
number of patients with gastrointestinal symptoms in this family is remarkable, as enterocolitis was 
thought to distinguish the NLRC4-associated AID from CAPS8. Hemophagocytosis was not observed. 
Response to treatment with an IL-1 receptor antagonist (anakinra) varied (Table 1). 
WES revealed the novel heterozygous c.1333T>C p.(Ser445Pro) variant in NLRC4 in all affected 
family members. This variant is absent in the dbSNP or ExAC databases. Prediction software programs 
(Sift score 0.01, Polyphen-2 score 0.997) indicate that this mutation is probably damaging. The mutation 
is located next to the recently described pathogenic c.1328A>C p.(His443Pro) mutation and segregated 
with the disease phenotype (LOD-score 3.58).  
Serum analysis of IL-1β, IL-6, IL-10, IL-18, TNFα, and IFNγ showed extremely elevated IL-18 
concentrations in 8 studied patients (median 4,324 pg/ml, range 3,097-13,984 pg/ml, normally 0-34 
pg/ml). Concentrations of the other cytokines were in the normal range. 
Skin biopsies were taken from nodes on the shins and/or calf of three adult patients. 
Histopathological examination in patient V5 showed a deep dermal and subcutaneous lymphocytic-
histiocytic infiltrate with (para)septal and lobular panniculitis. In patient VI5, a perivascular infiltrate of 
lymphocytes and perivascular edema was observed. Patient VI1 showed a perivascular and interstitial 
infiltrate of lymphocytes, and in the deep dermis an infiltrate of lymphocytes, histiocytes and a few mast 
cells (Fig. 1b). Vasculitis was absent in all samples. Skin biopsies of clinically uninvolved skin (V5 and VI1) 
showed no abnormalities (not shown). 
Skin biopsies in CAPS and in the related Schnitzler’s syndrome mostly show a neutrophilic 
dermal infiltrate without vasculitis12. The absence of a neutrophilic infiltrate in the skin biopsies of our 
patients is remarkable. Immunofluorescence studies did not detect IL-1β in the skin biopsies, whereas it 
was found in mast cells in a skin biopsy from a Schnitzler’s syndrome patient (data not shown). NLRC4 
could not be detected in affected or unaffected skin (not shown), whereas it was present in the positive 
control (spleen). 
In this pedigree, the response to anakinra varied widely, from no response to complete 
remission. The partial response to anakinra may be explained by the upregulated IL-18 production in 
response to NLRC4 inflammasome assembly. Additional deletion of the IL-18 receptor in mice with Nlrp3 
mutations, CAPS-mice, abolished the skin and visceral phenotype in young mice, and normalized the 
concentrations of most inflammatory markers in serum. However, with aging, a profound systemic 
inflammatory response occurred, even though the skin phenotype remained absent13. Possibly, IL-18 
plays a role in various stages of the disease and may explain the partial anakinra-resistance.  
CAPS-mice lacking both IL-1 and IL-18 receptors still showed clinical features associated with 
autoinflammation, indicating a role for additional players in the development of the autoinflammatory 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
phenotype as well 13. As caspase-1 deficiency provided protection from autoinflammation in CAPS-mice, 
it can be hypothesized that caspase-1 exerts additional effects in NLRC4-mediated autoinflammatory 
disease. This is supported by the caspase-1 dependent, but IL-1β and IL-18 independent, ‘eicosanoid 
storm’, which was recently described upon NLRC4 inflammasome activation in mice14. 
In conclusion, we describe a novel mutation in NLRC4 causing an NLRC4-associated, partially 
anakinra-responsive AID, dominated by cutaneous erythematous nodes and urticarial rash, arthralgias, 
and late-onset enterocolitis. We present the first histopathological study on the skin lesions, showing a 
lymphocytic-histiocytic infiltrate and septal/lobular panniculitis. The absence of both a neutrophilic 
dermal infiltrate and IL-1β-positive mast cells distinguishes the urticarial rash observed in NLRC4-
mediated AID from that observed in CAPS and Schnitzler’s syndrome. 
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Figure legends 
 
Fig 1. Skin features and histology in patients with the c.1333T>C p.Ser445Pro variant in NLRC4 
Urticarial skin rash in patient VII2, photographed at age 2 and 5 years old (at age 5 skin lesions appeared 
during temporary anakinra withdrawal): the face, trunk, extremities and soles are affected. 
Erythematous nodes on the lower legs of patient VI5; and on the lower legs (taken at the end of attack) 
and feet (during attack and at the end of attack) of patient VI2. 
Histopathological examination of lesional skin in patient V5 showed a deep dermal and subcutaneous 
lymphocytic-histiocytic infiltrate with (para)septal and lobular panniculitis; in patient VI5 a perivascular 
infiltrate of lymphocytes and perivascular edema without signs of vasculitis or urticaria; and in patient 
VI1 a perivascular and interstitial infiltrate of lymphocytes, and in the deep dermis a granulomatous 
infiltrate of lymphocytes, histiocytes and a few mast cells. Panel (a) shows 100x magnification; panel (b) 
400x magnification of the cellular infiltrate. Bar: 100nm. 
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Table 1 
Patient 
no. 
Current 
age (yrs) 
Age at 
disease 
onset 
(yrs) 
Gend
er 
Episodes 
 
Organs involved Responsiveness 
to Anakinra 
     Eyes Skin Joints/Muscle Gastro-
intestinal 
system 
Other  
IV1 88 5 F Intermittent, 
6x/yr 
Dry, 
conjunctivitis 
Itching skin 
rash, 
erythematous 
nodes 
Swelling, 
arthralgia, 
myalgia 
Colitis 
ulcerosa 
(age 75) 
Fatigue, 
elevated ESR, 
chronic renal 
insufficiency 
Not tried 
V1 63 <4 F Intermittent, 
frequency 
unknown 
Dry, 
conjunctivitis, 
episcleritis, 
cataract 
insipiens 
Urticarial rash, 
erythematous 
nodes, itch, 
edema of lower 
legs 
Swelling, 
arthrosis 
(Heberden 
noduli), 
rheumatic 
complaints 
- Elevated ESR, 
no response 
to medication 
Not tried 
V3 61 <4 F Intermittent, 
0-2x/yr 
- Painful skin 
rash, non-
itching.  
Pain, swelling, 
redness of 
joints. Myalgia. 
- - Not tried 
V5 58 Birth F Intermittent 
12-60x/yr 
Dry, 
conjunctivitis 
Painful 
erythematous 
nodes, itch.  
Swelling, 
erosive 
polyarthritis, 
tendinitis, 
osteoarthritis 
- - Partial response: 
good effect on 
skin phenotype. 
Worsening of 
erosive arthritis 
despite Anakinra 
V7 Deceased <7 F Intermittent, 
24x/yr 
Conjunctivitis Painful skin rash Swelling - - Not tried 
V8 70 <24 M unknown Dermatitis 
eyelids, 
conjunctivitis, 
episcleritis 
Urticarial rash, 
dermatitis neck, 
itch, psoriasis 
Painful joints, 
myalgia 
- Fever, 
sensorineural 
hearing loss 
Not tried 
V9 68 Child-
hood 
F unknown Conjunctivitis Urticarial rash Pain - Fever Not tried 
VI1 33 6 
months 
F Never 
symptom-
free, 
frequency of 
flares varies 
Conjunctivitis, 
recurrent 
uveitis, 
keratitis, 
episcleritis 
Urticarial rash 
(age 12 yrs), 
erythema 
nodosum, 
secondary 
- - Fatigue, 
lymphedema, 
temporary 
IgA-
deficiency, 
Not tried 
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lymphedema elevated CRP 
VI5 32 6 F Intermittent, 
2x/yr.  
Before 
Anakinra 
continuously 
subfebrile 
temperature 
Dry, 
conjunctivitis 
Urticarial rash, 
painful 
erythematous 
nodes, itch, 
eczema 
Pain, swelling, 
stiffness 
Inflamma-
tory bowel 
disease, 
developed 
during 
treatment 
with 
Canakinuma
b 
- Good effect on 
skin phenotype 
and subfebrile 
temperature 
VI7 39 unknow
n 
M unknown Dry Urticarial rash + - - Not tried 
VII1 7 9 
months 
F Continuous 
rash; 
intermittent 
flares, 
frequency 
varies 
Conjunctivitis Urticarial rash; 
non-itching  
Red, painful, 
swelling 
- Microcytic 
anemia, 
elevated CRP 
Not tried 
VII2 6 Birth F Intermittent, 
12x/yr. 
Continuous 
complaints 
without 
Anakinra 
Conjunctivitis Urticarial rash Painful, swelling - Fever 
(infrequent)/ 
subfebrile 
temperature, 
microcytic 
anemia, 
elevated CRP 
yes, immediate 
flare up once 
treatment with 
Anakinra is 
interrupted 
VII3 8 2 
months 
F Continuous - Urticarial rash + - - Not tried 
Table 1: Patient characteristics: Legends: All patients carry the c.1333T>C (p.Ser445Pro) mutation in NLRC4. Patient numbers are indicated similar to 
numbering in pedigree. Gender: F, female; M, male.  
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